Form 8-K - Current report:
SEC Accession No. 0001628280-15-008912
Filing Date
2015-11-20
Accepted
2015-11-20 17:16:48
Documents
3
Period of Report
2015-11-20
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a8kacetadote-november2015.htm 8-K 40386
2 EXHIBIT 99.1 pressreleasenov2015acetado.htm EX-99.1 13026
3 cumberlandpicturea03.jpg GRAPHIC 154951
  Complete submission text file 0001628280-15-008912.txt   267610
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 151247518
SIC: 2834 Pharmaceutical Preparations